Colleen Tupper - Feb 10, 2022 Form 4/A - Amendment Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Role
EVP & Chief Financial Officer
Signature
/s/ Colleen Tupper
Stock symbol
COLL
Transactions as of
Feb 10, 2022
Transactions value $
-$71,543
Form type
4/A - Amendment
Date filed
3/3/2022, 03:13 PM
Date Of Original Report
Feb 14, 2022
Previous filing
May 24, 2021
Next filing
Oct 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Award $0 +52.5K +125% $0.00 94.5K Feb 10, 2022 Direct F1
transaction COLL Common Stock Award +4.21K +4.46% 98.7K Feb 10, 2022 Direct F2
transaction COLL Common Stock Tax liability -$49.7K -2.82K -2.86% $17.63 95.9K Feb 10, 2022 Direct F3
transaction COLL Common Stock Tax liability -$21.8K -1.24K -1.29% $17.63 94.7K Feb 10, 2022 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2023, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.
F2 On February 10, 2022, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 4,212 performance share units granted in the issuer's prior fiscal year.
F3 Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
F4 Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units.

Remarks:

The original Form 4 filed on February 14, 2022 is amended by this Form 4 amendment to reflect the correct number of securities acquired by the reporting person. Due to an administrative error, the original Form 4 misreported a grant of restricted stock units to the reporting person on February 10, 2022. The number of restricted stock units acquired by the reporting person in Row 1 of Table 1 has been corrected. The transactions listed in Rows 2, 3 and 4 of Table I of this Form 4 amendment are not new or revised.